We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.2B
AUM Growth
+$6.6B
Cap. Flow
+$3.75B
Cap. Flow %
16.89%
Top 10 Hldgs %
18.16%
Holding
1,735
New
565
Increased
342
Reduced
340
Closed
467

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
AAPL icon
Apple
AAPL
+$213M
3
ELV icon
Elevance Health
ELV
+$188M
4
BMY icon
Bristol-Myers Squibb
BMY
+$184M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$166M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$183M
2
ABBV icon
AbbVie
ABBV
+$149M
3
HUM icon
Humana
HUM
+$120M
4
FIS icon
Fidelity National Information Services
FIS
+$119M
5
MELI icon
Mercado Libre
MELI
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 17.93%
3 Consumer Discretionary 11.98%
4 Financials 8.85%
5 Communication Services 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADBE icon
701
Adobe
ADBE
$109B
$2.45M 0.01%
4,888
-377,908
-99% -$183M
CFG icon
702
Citizens Financial Group
CFG
$30.6B
$2.44M 0.01%
+68,356
New +$2.14M
MLAB icon
703
Mesa Laboratories
MLAB
$569M
$2.44M 0.01%
8,520
-1,441
-14% -$396K
OMC icon
704
Omnicom Group
OMC
$23.2B
$2.44M 0.01%
+39,138
New +$2.24M
MBUU icon
705
Malibu Boats
MBUU
$568M
$2.41M 0.01%
38,677
-18,034
-32% -$1.04M
TDOC icon
706
Teladoc Health
TDOC
$1.29B
$2.41M 0.01%
12,060
+7,249
+151% +$1.47M
APO icon
707
Apollo Global Management
APO
$76B
$2.39M 0.01%
+48,719
New +$2.18M
CERT icon
708
Certara
CERT
$1.23B
$2.38M 0.01%
+70,731
New +$2.59M
SNP
709
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$2.38M 0.01%
+53,376
New +$2.3M
WNS
710
DELISTED
WNS Holdings
WNS
$2.37M 0.01%
32,912
-3,745
-10% -$251K
DCBO
711
Docebo
DCBO
$594M
$2.34M 0.01%
+35,953
New +$1.91M
DRH icon
712
Diamondrock Hospitality Co
DRH
$2.48B
$2.34M 0.01%
+283,668
New +$1.9M
OPK icon
713
Opko Health
OPK
$1.04B
$2.34M 0.01%
+591,074
New +$2.47M
ARCH
714
DELISTED
Arch Resources, Inc.
ARCH
$2.33M 0.01%
+53,326
New +$1.99M
BXP icon
715
Boston Properties
BXP
$10.8B
$2.33M 0.01%
+24,667
New +$2.2M
AFYA icon
716
Afya
AFYA
$1.23B
$2.32M 0.01%
91,807
-22,956
-20% -$591K
HARP
717
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.31M 0.01%
+13,904
New +$2.15M
ABMD
718
DELISTED
Abiomed Inc
ABMD
$2.3M 0.01%
7,102
-738
-9% -$204K
GT icon
719
Goodyear
GT
$1.74B
$2.29M 0.01%
+210,249
New +$2.12M
PHAT icon
720
Phathom Pharmaceuticals
PHAT
$693M
$2.29M 0.01%
+68,996
New +$2.8M
RDS.A
721
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.29M 0.01%
65,021
+24,773
+62% +$773K
GOLF icon
722
Acushnet Holdings
GOLF
$5.34B
$2.27M 0.01%
+56,112
New +$2.1M
AMCX icon
723
AMC Global Media
AMCX
$489M
$2.27M 0.01%
+63,619
New +$1.78M
LPSN icon
724
LivePerson
LPSN
$31.2M
$2.26M 0.01%
+2,420
New +$2.08M
VRSK icon
725
Verisk Analytics
VRSK
$23.6B
$2.25M 0.01%
10,844
-42,097
-80% -$8.18M
27 28
29
30 31

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace North America held 1,735 positions worth $22.2B, up 42% from $15.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $3.75B of net new capital in Q4 2020, opening 565 new positions and adding to 342 existing holdings. Its largest new stake was ExxonMobil: 2,686,885 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Adobe, an estimated $183M trimmed.

  • Marshall Wace North America's largest Q4 2020 buy was ExxonMobil: 2,686,885 shares worth $111M.
  • Marshall Wace North America added most to Thermo Fisher Scientific in Q4 2020, an estimated $239M increase.
  • Marshall Wace North America's biggest Q4 2020 reduction was Adobe, cutting an estimated $183M.
  • Marshall Wace North America fully exited Baxter International in Q4 2020, selling an estimated $92.8M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $22.2B portfolio in Q4 2020.
  • Marshall Wace North America opened 565 new positions and closed 467 in Q4 2020.
  • Marshall Wace North America's portfolio value rose 42% quarter-over-quarter to $22.2B.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.